Medpace Holdings Reports Strong Q4 Earnings, Surpassing Expectations
Cincinnati, OH - Medpace Holdings Inc. (MEDP) today announced financial results for the fourth quarter, reporting a net income of $117 million ($3.67 per share). This exceeded Wall Street analysts' consensus estimate of $2.97 per share.
Revenue for the quarter reached $536.6 million, also exceeding analysts' expectations of $536.4 million.
The provider of outsourced clinical development services expects full-year earnings to be in the range of $11.93 to $12.69 per share, with revenue between $2.11 billion and $2.21 billion.
Medpace's strong financial performance reflects its leadership in the clinical research industry. The company offers a comprehensive suite of services, including protocol design, patient recruitment, data management, and statistical analysis.